Product NDC: | 45802-368 |
Proprietary Name: | Imiquimod |
Non Proprietary Name: | Imiquimod |
Active Ingredient(s): | 12.5 mg/.25g & nbsp; Imiquimod |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-368 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078837 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101109 |
Package NDC: | 45802-368-53 |
Package Description: | 12 PACKET in 1 CARTON (45802-368-53) > .25 g in 1 PACKET |
NDC Code | 45802-368-53 |
Proprietary Name | Imiquimod |
Package Description | 12 PACKET in 1 CARTON (45802-368-53) > .25 g in 1 PACKET |
Product NDC | 45802-368 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Imiquimod |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20101109 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | IMIQUIMOD |
Strength Number | 12.5 |
Strength Unit | mg/.25g |
Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |